Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=24832604
&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215
Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\24832604
.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117 Cell+Death+Dis
2014 ; 5
(5
): e1232
Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
Understanding the roadmaps to induced pluripotency
#MMPMID24832604
Liu K
; Song Y
; Yu H
; Zhao T
Cell Death Dis
2014[May]; 5
(5
): e1232
PMID24832604
show ga
Somatic cells can be reprogrammed into induced pluripotent stem cells (iPSCs) by
ectopic expression of transcription factors Oct4, Sox2, Klf4 and cMyc. Recent
advancements have shown that small-molecule compounds can induce pluripotency,
indicating that cell fate can be regulated by direct manipulation of intrinsic
cell signaling pathways, thereby innovating our current understanding of
reprogramming. The fact that lineage specifiers can induce pluripotency suggests
that the pluripotent state is a fine balance between competing differentiation
forces. Dissection of pluripotent roadmaps indicates that reprogramming is a
process of reverse development, involving a series of complicated and distinct
reprogramming stages. Evidence from mouse iPSC transplantation studies
demonstrated that some certain but not all cells derived from iPSCs are
immunogenic. These studies provide new ways to minimize reprogramming-induced
abnormalities and maximize reprogramming efficiency to facilitate clinical
development and use of iPSCs.